Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: liposomal Doxorubicin|DRUG: Myocet / Paclitaxel
Sponsor: Claudia Lorenz-Schlüter